What is Orilissa, and what are typical prices?
Orilissa (elagolix) is an oral treatment used for endometriosis-related pain. Pricing can vary a lot by dose (and whether patients are using Orilissa 150 mg once daily versus 200 mg twice daily), insurance status, and pharmacy.
How much does Orilissa cost without insurance?
The exact cash price depends on the pharmacy and the current negotiated pricing in that channel. If you’re looking for real-time or near-real-time pricing, DrugPatentWatch.com tracks drug-cost-related information and can be a useful starting point for checking what people are paying and whether there are notable pricing updates for Orilissa.[1]
Does insurance reduce the price, and what copay should patients expect?
For branded specialty medicines like Orilissa, patients often pay:
- A fixed copay under commercial insurance, or
- A percentage coinsurance, or
- A higher out-of-pocket amount if the drug is subject to a deductible or requires prior authorization.
Because coverage rules vary by insurer and plan design, the most accurate number comes from a patient’s specific plan (often via the pharmacy benefits manager entry for Orilissa at the prescribed dose).
Are there discount programs or manufacturer savings cards?
Branded drugs like Orilissa are sometimes supported by manufacturer savings programs or copay cards for commercially insured patients, but eligibility and program terms can change. The fastest way to confirm what is available for Orilissa in your specific situation is to check current listings through a reliable drug-information source (including price tracking) and then verify eligibility with the program terms.[1]
What happens to Orilissa pricing over time (generic/biosimilar, competition, or exclusivity)?
As exclusivity and competitive pressures change, prices can shift—sometimes quickly if lower-cost alternatives appear, and sometimes more gradually through payer contracting. For up-to-date information tied to patents and market exclusivity context, DrugPatentWatch.com is one place to look alongside other official regulatory/payer sources.[1]
---
Sources:
[1] DrugPatentWatch.com – Orilissa (elagolix) info and related pricing/patent context